Physician profile
Benjamin Weisman
NPI 1427053073
$2,530.36
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,931 · 2020: $535 · 2021: $21.34 · 2023: $42.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $42.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $42.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $671.58 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $314.22 | 2019-2020 | |
| Glaxosmithkline, LLC. | $211.45 | 2019-2020 | |
| Lilly USA, LLC | $208.66 | 2019-2020 | |
| Novo Nordisk INC | $186.82 | 2019-2020 | |
| Allergan, INC. | $152.08 | 2019-2020 | |
| Abbvie INC. | $83.97 | 2019-2023 | Avycaz, Qulipta |
| Novartis Pharmaceuticals Corporation | $73.80 | 2019 | |
| Radius Health, INC. | $67.82 | 2019 | |
| Merck Sharp & Dohme LLC | $66.62 | 2019 | |
| Mylan Specialty L.P. | $66.18 | 2019 | |
| Genzyme Corporation | $65.76 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $56.71 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.10 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $36.93 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $31.84 | 2019 | |
| Jazz Pharmaceuticals INC. | $27.40 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $26.96 | 2019-2020 | |
| Amgen INC. | $24.95 | 2019 | |
| Pfizer INC. | $20.42 | 2019 | |
| Optinose US, INC. | $19.37 | 2020 | |
| Insmed, INC. | $18.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.63 | 2019 | |
| Sanofi Pasteur INC. | $15.20 | 2019 | |
| Ironwood Pharmaceuticals, INC | $14.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Weisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.